Artemis Medicare Services Limited

NSE ARTEMISMED.NS

Artemis Medicare Services Limited Operating Income for the year ending March 31, 2024: USD 19.24 M

Artemis Medicare Services Limited Operating Income is USD 19.24 M for the year ending March 31, 2024, a 144.12% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Artemis Medicare Services Limited Operating Income for the year ending March 31, 2023 was USD 7.88 M, a 31.92% change year over year.
  • Artemis Medicare Services Limited Operating Income for the year ending March 31, 2022 was USD 5.97 M, a 202.95% change year over year.
  • Artemis Medicare Services Limited Operating Income for the year ending March 31, 2021 was USD 1.97 M, a -55.09% change year over year.
  • Artemis Medicare Services Limited Operating Income for the year ending March 31, 2020 was USD 4.39 M, a -21.10% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
SV Wall Street
NSE: ARTEMISMED.NS

Artemis Medicare Services Limited

CEO Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology
IPO Date Jan. 24, 2020
Location India
Headquarters Artemis Hospital
Employees 1,991
Sector Healthcare
Industries
Description

Artemis Medicare Services Limited manages and operates multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a 541 bed multi-specialty hospital located in Gurugram, India. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.

Similar companies

ASALCBR.NS

Associated Alcohols & Breweries Limited

USD 15.63

-3.08%

INDRAMEDCO.NS

Indraprastha Medical Corporation Limited

USD 5.31

0.02%

BRNL.NS

Bharat Road Network Limited

USD 0.46

-1.55%

EMAMIPAP.NS

Emami Paper Mills Limited

USD 1.16

-0.74%

CHEMBOND.NS

Chembond Chemicals Limited

USD 6.54

-0.78%

StockViz Staff

February 10, 2025

Any question? Send us an email